comparemela.com

MaxCyte, Inc. (NASDAQ:MXCT – Get Rating) CEO Douglas Doerfler sold 27,862 shares of the company’s stock in a transaction on Thursday, April 6th. The stock was sold at an average price of $5.03, for a total transaction of $140,145.86. Following the completion of the sale, the chief executive officer now owns 333,197 shares of the […]

Related Keywords

Massachusetts ,United States ,Blackrock ,Douglas Doerfler ,Maxcyte Company Profile ,Millennium Management ,Massachusetts Financial Services Co ,Blackrock Inc ,Maxcyte Inc ,Nasdaq ,Vanguard Group Inc ,Get Rating ,Water Life Science Advisors ,Financial Services ,Maxcyte Daily ,Maxcyte ,Nasdaq Mxct ,Mxct ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.